Mirogabalin activates the descending noradrenergic system by binding to the α2δ-1 subunit of voltage-gated Ca2+ channels to generate analgesic effects
Gabapentinoids such as gabapentin and pregabalin, which bind specifically to the α2δ subunit of voltage-gated Ca2+ channels, are used for first-line treatment of neuropathic pain. Here, we examined the analgesic effect of mirogabalin besilate (referred to simply as mirogabalin), a novel gabapentinoi...
Main Authors: | Misa Oyama, Shun Watanabe, Takashi Iwai, Mitsuo Tanabe |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-05-01
|
Series: | Journal of Pharmacological Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1347861321000037 |
Similar Items
-
Long-Term Safety and Efficacy of Mirogabalin for Central Neuropathic Pain: A Multinational, Phase 3, 52-Week, Open-Label Study in Asia
by: Takahiro Ushida, et al.
Published: (2023-04-01) -
Mirogabalin—A Novel Selective Ligand for the α2δ Calcium Channel Subunit
by: Renata Zajączkowska, et al.
Published: (2021-01-01) -
Long‐term safety and efficacy of mirogabalin in Asian patients with diabetic peripheral neuropathic pain
by: Masayuki Baba, et al.
Published: (2020-05-01) -
Frequency of Adverse Drug Reactions and Analgesic Effects of Mirogabalin during Treatment of Peripheral Neuropathic Pain: A Retrospective Clinical Investigation
by: Kazuhide Inage, et al.
Published: (2020-10-01) -
Mirogabalin for the treatment of diabetic peripheral neuropathic pain: A randomized, double‐blind, placebo‐controlled phase III study in Asian patients
by: Masayuki Baba, et al.
Published: (2019-09-01)